The Shifting Sands of Global Health: Aid, Addiction and AI Nairobi, Kenya – The landscape of global health is undergoing a dramatic transformation. As traditional aid structures face headwinds, new players and technologies are emerging, offering both promise and peril. A recent panel hosted by the French Chamber of Commerce in Kenya underscored a critical … Read more
The Weight Loss Drug Rollercoaster: What Happens When You Stop Ozempic or Mounjaro? Injectable weight-loss medications like semaglutide (Ozempic) and tirzepatide (Mounjaro) have dramatically changed how obesity is treated, helping many people achieve significant weight loss. However, a growing body of research suggests these benefits may be temporary if treatment is halted. Understanding what happens … Read more
Beyond Weight Loss: GLP-1 Drugs Show Promise in Treating Chronic Migraines For millions grappling with chronic migraines, a new potential treatment avenue is emerging – one initially designed for diabetes and weight management. Preliminary research suggests that GLP-1 receptor agonists, like Ozempic and Wegovy, may significantly reduce the demand for emergency care related to migraines … Read more
Delaware Faces Key Decisions on Healthcare, Energy, and Education Funding Delaware residents will have multiple opportunities this week to weigh in on critical state issues, from potential changes to employee health insurance and the rising demand for energy to proposed reforms in public education funding. Several public meetings are scheduled, offering citizens a direct line … Read more
The Unexpected Return of Scurvy: A Side Effect of the Weight-Loss Drug Boom? A condition once synonymous with long sea voyages and vitamin C deficiency – scurvy – is making an unexpected comeback, and it’s being linked to the rising popularity of GLP-1 medications like Ozempic. These drugs, initially developed for diabetes management, have gained … Read more
The Unexpected Side Effect of Weight Loss Drugs: A Return to ‘Pirate Disease’ The soaring popularity of GLP-1 weight-loss drugs like Ozempic, Wegovy, and Mounjaro has brought a surprising health concern to light: scurvy, a disease historically associated with pirates and severe vitamin C deficiency. Although these medications offer significant benefits for weight management, a … Read more
The Weight Loss Revolution: How Medicare Coverage is Reshaping the Future of Obesity Treatment The landscape of weight loss treatment is undergoing a dramatic shift. Recent decisions regarding Medicare coverage for GLP-1 medications like Ozempic and Wegovy, coupled with the impending launch of Eli Lilly’s new obesity pill, orforglipron, are poised to significantly impact millions … Read more
The Pill is the New Shot: How Sam Chun Dang is Pioneering Oral Weight Loss & Beyond The race to deliver weight-loss medications in pill form is heating up, and South Korea’s Sam Chun Dang Pharm (SCD) is rapidly emerging as a frontrunner. A recent surge in the company’s stock – up over 75% this … Read more
Beyond Ozempic: The Future of GLP-1s and Nutritional Harmony The buzz around medications like Ozempic and Wegovy is undeniable. These GLP-1 receptor agonists have revolutionized weight management for many, but their success isn’t simply about a shot. As University of Maine professor Mary Ellen Camire emphasizes, these drugs are a tool, not a miracle. The … Read more
The Ozempic Effect: Beyond the Quick Fix and What the Future Holds for Weight Loss Drugs As New Year’s resolutions often center around weight loss, the demand for medications like Ozempic, Wegovy, and other GLP-1 receptor agonists has surged. But a growing body of evidence, and warnings from doctors like bariatric surgeon Dr. Katelin Mirkin, … Read more